Bernstein keeps Givaudan stock at Underperform
Published on 10/02/2026 at 13:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Givaudan (ISIN CH0010645932) stock was trading at EUR 3,593.00 at Lang & Schwarz on October 2, 2026 at 1:37 p.m. CEST, up 0.59 percent versus the prior close of EUR 3,572.00. The latest analyst signal came from Bernstein Research, which kept its Underperform rating and CHF 2,886 price target in a note dated October 1, 2026.
Bernstein keeps negative rating
According to finanzen.ch on October 2, 2026, Bernstein analyst Victoria Nice described Givaudan's investor day on the European business of Taste & Wellbeing as informative rather than a factor for the stock. The CHF 2,886 target stands below the reported Swiss-market quotation of CHF 3,340.18 in the analyst summary, highlighting a more cautious view than the broader recent coverage.
Sales growth and margin matter
Givaudan's investor page reports fiscal 2025 group sales of CHF 7.472 billion, up 5.1 percent on a like-for-like basis and 0.8 percent in Swiss francs from fiscal 2024. Givaudan also lists fiscal 2025 EBITDA of CHF 1.751 billion, an EBITDA margin of 23.4 percent, net income of CHF 1.071 billion and a dividend of CHF 72.00 per share.
That combination gives the stock two opposing reference points: the operating business produced 5.1 percent like-for-like sales growth in fiscal 2025, while Bernstein's current target is materially below the market quotation cited in its October 1 note. For investors, the next sales update will help test whether growth can continue without eroding profitability.
Carbon program reaches 90,000 products
On September 21, 2026, Givaudan said its Product Carbon Footprint program had received dual certification and covered more than 90,000 products. The announcement adds a measurable customer and reporting dimension to the group's fragrance, beauty, taste and wellbeing operations.
October sales date approaches
MarketScreener lists October 12, 2026, for Givaudan's third-quarter sales and revenue release. Earlier, Barclays raised its target from CHF 3,300 to CHF 3,450 while retaining Equal Weight, and projected 5.6 percent operating quarterly growth in a September 21 note, according to wallstreetONLINE.
Stock stays near yearly high
Givaudan's market capitalization was CHF 30.9 billion as of October 2, 2026, while the primary-market 52-week range was CHF 2,566.00 to CHF 3,592.00. The Lang & Schwarz price was therefore quoted in euros at a level that requires separate currency interpretation from the SIX range.
The Lang & Schwarz quote was EUR 3,593.00 on October 2, 2026 at 1:37 p.m. CEST, plus 0.59 percent versus the prior close of EUR 3,572.00. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.
Givaudan stock facts
- Company: Givaudan S.A.
- ISIN: CH0010645932
- Ticker: GIVN
- Primary exchange: SIX Swiss Exchange
- Price Lang & Schwarz (as of October 2, 2026, 1:37 p.m. CEST): EUR 3,593.00
- Change versus prior close: plus 0.59 percent
- Prior close Lang & Schwarz (October 1, 2026): EUR 3,572.00
- Market capitalization: CHF 30.9 billion (as of October 2, 2026)
- 52-week range: CHF 2,566.00-3,592.00 (as of October 2, 2026)
- Sector / Industry: Basic Materials / Specialty Chemicals
- Index membership: SMI, SPI and SLI
- Next earnings date: October 12, 2026
